Issue Date: December 16, 2020
Issued by: Center for Drug Evaluation and Research
Topic(s): Clinical – Medical
Status: Draft
Dry Eye: Developing Drugs for Treatment Guidance for Industry
Comments and suggestions regarding this draft document should be submitted within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit electronic comments to https://www.regulations.gov. Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that publishes in the Federal Register. For questions regarding this draft document, contact Wiley Chambers at 301-796-0690.
Download the Guidance Document
